Experts warn that the Trump administration’s new $100,000 fee for H-1B visa applications could worsen healthcare’s workforce ...

Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for treating obesity.

The government shutdown is drawing backlash from healthcare leaders over its potential to disrupt ACA subsidies, Medicare ...

MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, also discussed ...

Capital Rx, a transparent pharmacy benefit manager, has secured a $400 million investment and is rebranding under the name Judi Health as it expands beyond pharmacy benefits, the company announced on ...

Nearly half of healthcare executives plan to leave their organizations within the next year, according to a recent survey. Such significant turnover puts healthcare organizations at risk for ...

Digital health funding is holding steady — venture capital is flowing, IPOs are reappearing, and megarounds are back in force. Startups in this space have raised $9.9 billion throughout the first ...

Novo Nordisk can reach MASH patients with the recent FDA decision expanding approval of its GLP-1 drug Wegovy to the treatment of moderate-to-advanced cases of the fatty liver disease. Now it’s ...

Boehringer Ingelheim established a presence in idiopathic pulmonary fibrosis years ago with a drug that has become a standard treatment for this serious lung disorder. Now the company has the ...

At MedCity News’ INVEST Digital Health conference, healthcare experts explored strategies to mitigate automation bias — emphasizing the importance of vendor responsibility, use case-specific ...

Healthcare has been moving steadily out of the clinic and into the home. McKinsey estimates that as much as $265 billion in care (nearly a quarter of all Medicare spending) could shift from facilities ...